{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:48:35Z","timestamp":1792018115293,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T00:00:00Z","timestamp":1407024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11882-014-0462-4","type":"journal-article","created":{"date-parts":[[2014,8,2]],"date-time":"2014-08-02T08:19:48Z","timestamp":1406967588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Autoimmune Lymphoproliferative Syndrome: an Update and Review of the Literature"],"prefix":"10.1007","volume":"14","author":[{"given":"Shaili","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Koneti","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa K.","family":"Tarrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,3]]},"reference":[{"issue":"22","key":"462_CR1","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","volume":"118","author":"VK Rao","year":"2011","unstructured":"Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood. 2011;118(22):5741\u201351. Discusses management of various complications related to ALPS based on study of a large cohort of ALPS patients.","journal-title":"Blood"},{"issue":"6","key":"462_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81(6):935\u201346.","journal-title":"Cell"},{"issue":"1","key":"462_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98(1):194\u2013200.","journal-title":"Blood"},{"issue":"1","key":"462_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2013.02.019","volume":"147","author":"F Hauck","year":"2013","unstructured":"Hauck F et al. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation. Clin Immunol. 2013;147(1):61\u20138.","journal-title":"Clin Immunol"},{"issue":"4","key":"462_CR5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","volume":"108","author":"M Del-Rey","year":"2006","unstructured":"Del-Rey M et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood. 2006;108(4):1306\u201312.","journal-title":"Blood"},{"issue":"3","key":"462_CR6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00439-006-0138-9","volume":"119","author":"S Zhu","year":"2006","unstructured":"Zhu S et al. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet. 2006;119(3):284\u201394.","journal-title":"Hum Genet"},{"issue":"1","key":"462_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","volume":"98","author":"J Wang","year":"1999","unstructured":"Wang J et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98(1):47\u201358.","journal-title":"Cell"},{"issue":"3","key":"462_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3324\/haematol.2012.067488","volume":"98","author":"O Lambotte","year":"2013","unstructured":"Lambotte O et al. Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults. Haematologica. 2013;98(3):389\u201392.","journal-title":"Haematologica"},{"issue":"1","key":"462_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-003-0830-2","volume":"23","author":"M Deutsch","year":"2004","unstructured":"Deutsch M, Tsopanou E, Dourakis SP. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood. Clin Rheumatol. 2004;23(1):43\u20134.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"462_CR10","doi-asserted-by":"crossref","first-page":"e1440","DOI":"10.1542\/peds.2012-2748","volume":"132","author":"A Rudman Spergel","year":"2013","unstructured":"Rudman Spergel A et al. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis. Pediatrics. 2013;132(5):e1440\u20134.","journal-title":"Pediatrics"},{"issue":"1","key":"462_CR11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","volume":"121","author":"A Magerus-Chatinet","year":"2011","unstructured":"Magerus-Chatinet A et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Investig. 2011;121(1):106\u201312.","journal-title":"J Clin Investig"},{"issue":"18","key":"462_CR12","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven B et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798\u2013807.","journal-title":"Blood"},{"issue":"7","key":"462_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ajh.20851","volume":"82","author":"YJ Kim","year":"2007","unstructured":"Kim YJ et al. Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome. Am J Hematol. 2007;82(7):615\u201324.","journal-title":"Am J Hematol"},{"issue":"4","key":"462_CR14","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","volume":"125","author":"I Caminha","year":"2010","unstructured":"Caminha I et al. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2010;125(4):946\u20139.e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"462_CR15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clinbiochem.2012.01.016","volume":"45","author":"RA Bowen","year":"2012","unstructured":"Bowen RA et al. Elevated vitamin B(1)(2) levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes. Clin Biochem. 2012;45(6):490\u20132.","journal-title":"Clin Biochem"},{"issue":"14","key":"462_CR16","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35\u201340. Discusses current diagnostic criteria for ALPS.","journal-title":"Blood"},{"issue":"2","key":"462_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0022-3859.81873","volume":"57","author":"NK Desai","year":"2011","unstructured":"Desai NK et al. Autoimmune lymphoproliferative disorder in an adult patient. J Postgrad Med. 2011;57(2):131\u20133.","journal-title":"J Postgrad Med"},{"issue":"7","key":"462_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pbc.21965","volume":"52","author":"VK Rao","year":"2009","unstructured":"Rao VK et al. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer. 2009;52(7):847\u201352.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"462_CR19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0609.2007.00924.x","volume":"79","author":"A Wei","year":"2007","unstructured":"Wei A, Cowie T. Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7\u2009+\u20092T\u2009>\u2009C) affecting the Fas gene. Eur J Haematol. 2007;79(4):363\u20136.","journal-title":"Eur J Haematol"},{"issue":"2","key":"462_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12288-011-0058-2","volume":"27","author":"S Arora","year":"2011","unstructured":"Arora S et al. Autoimmune lymphoproliferative syndrome: response to mycophenolate mofetil and pyrimethamine\/sulfadoxine in a 5-year-old child. Indian J Hematol Blood Transfus. 2011;27(2):101\u20133.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"462_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","volume":"145","author":"DT Teachey","year":"2009","unstructured":"Teachey DT et al. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol. 2009;145(1):101\u20136.","journal-title":"Br J Haematol"},{"issue":"6","key":"462_CR22","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2006-01-010124","volume":"108","author":"DT Teachey","year":"2006","unstructured":"Teachey DT et al. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood. 2006;108(6):1965\u201371.","journal-title":"Blood"},{"issue":"2","key":"462_CR23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pbc.23144","volume":"57","author":"R Bajwa","year":"2011","unstructured":"Bajwa R, Savelli S, Gross T. Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome. Pediatr Blood Cancer. 2011;57(2):336\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"462_CR24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0609.2005.00437.x","volume":"75","author":"R Kotb","year":"2005","unstructured":"Kotb R et al. Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Eur J Haematol. 2005;75(1):60\u20134.","journal-title":"Eur J Haematol"},{"issue":"2","key":"462_CR25","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.4081\/pr.2011.e15","volume":"3","author":"P Farruggia","year":"2011","unstructured":"Farruggia P et al. Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome. Pediatr Rep. 2011;3(2):e15.","journal-title":"Pediatr Rep"},{"issue":"5","key":"462_CR26","doi-asserted-by":"crossref","first-page":"e36698","DOI":"10.1371\/journal.pone.0036698","volume":"7","author":"Y Liang","year":"2012","unstructured":"Liang Y et al. Rituximab for children with immune thrombocytopenia: a systematic review. PLoS One. 2012;7(5):e36698.","journal-title":"PLoS One"},{"issue":"13","key":"462_CR27","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123(13):1989\u201399. Discusses long term follow-up, including morbidity and mortality, of a large cohort of ALPS patients.","journal-title":"Blood"},{"key":"462_CR28","doi-asserted-by":"crossref","unstructured":"Price S, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014.","DOI":"10.1182\/blood-2013-10-535393"},{"key":"462_CR29","doi-asserted-by":"crossref","unstructured":"Boggio E, et al. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. Blood. 2013.","DOI":"10.1182\/blood-2013-07-518167"},{"issue":"8","key":"462_CR30","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.1830270831","volume":"27","author":"M Benkerrou","year":"1997","unstructured":"Benkerrou M et al. Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol. 1997;27(8):2043\u20137.","journal-title":"Eur J Immunol"},{"issue":"6","key":"462_CR31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705775","volume":"40","author":"MN Dimopoulou","year":"2007","unstructured":"Dimopoulou MN et al. Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion. Bone Marrow Transplant. 2007;40(6):605\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"462_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bmt.1701306","volume":"22","author":"BJ Sleight","year":"1998","unstructured":"Sleight BJ et al. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant. 1998;22(4):375\u201380.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"462_CR33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/PAS.0b013e3181d5ddf8","volume":"34","author":"G Venkataraman","year":"2010","unstructured":"Venkataraman G et al. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol. 2010;34(4):589\u201394.","journal-title":"Am J Surg Pathol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-014-0462-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0462-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:57:15Z","timestamp":1649858235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-014-0462-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,3]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s11882-014-0462-4","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,3]]},"article-number":"462"}}